过程(计算)
计算机科学
一致性(知识库)
医药制造业
鉴定(生物学)
质量(理念)
可靠性工程
工艺工程
工程类
人工智能
医学
植物
认识论
生物
操作系统
药理学
哲学
作者
Jens Lamerz,Oana Danila,Andreas Schuster,Janine Burren,Christian Moessner,Wolfgang Göhring,Pankaj D. Rege,Helmut Stahr,Stefan Hildbrand,Daniel J. Coleman
出处
期刊:Pda Journal of Pharmaceutical Science and Technology
[Parenteral Drug Association, Inc.]
日期:2022-01-01
卷期号:76 (6): 497-508
被引量:3
标识
DOI:10.5731/pdajpst.2021.012662
摘要
The identification of critical process parameters in biologics and small molecule process development is a key element of quality by design. The objectivity and consistency of procedures to identify critical process parameters can be improved with the use of impact ratios. Impact ratios quantify a process parameter's practical effect on a critical quality attribute relative to the critical quality attribute's acceptance limits. If the impact ratio is large, i.e., exceeds a predefined impact ratio threshold, the recommendation is to classify the process parameter as a critical process parameter. This article introduces an improved and mathematically well-defined impact ratio. Benefits of this impact ratio are a consistent interpretation for many scenarios commonly encountered in practice, high suitability to automation, and the possibility of standardizing on a single impact ratio definition for pharmaceutical manufacturing.
科研通智能强力驱动
Strongly Powered by AbleSci AI